Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis

Table 3 Secondary outcome data

	Average time to theatre (days): CG/NCG	P-value	Length of hospital stay (days): CG/NCG	P-value	Complications
	Average time to theatre (days): CG/NCG	P-value	Length of hospital stay (days): CG/NCG	P-value	Haematoma/Haemorrhage (n)^a: CG/NCG	P-value	Cardiovasc cerebrovasc/TE (n): CG/NCG	P-value	Death within 30 days (n):CG/NCG	P-value
Harty et al 2007 [68]	7.2/2.1	0.03	7.4/3.1	0.02					6/6	0.003
Johansen et al 2008 [56]	2.7/7.3						0/2
Sim and Gonski 2009 [57] CG vs NG	3.5 (3.2)/0.9 (0.8)	<0.001	23.1 (17.7)/22.6 (21.4)	0.92	1/1				1/2
Cox et al 2009 [58]			25/30	<0.05			2/0		2/1
Nydick et al 2010 [53]	1.88/1.68	0.64			0/0		1/1		0/1	0.35
Chechik et al 2011 [52]	2.5 (1.5)/1.6 (0.96)	0.003			1/1		6/1		0/0
Wallace et al 2012 [63]
Collinge et al 2012 [62]			6.0 (3.4)/5.6 (4.0)	0.61	0/10	0.89	0/9	0.95	3/39	0.23
Chechik et al 2012 [59]	1.7 (1)/7.5 (2.71)	<0.001	11.1 (4.8)/17.7 (7.2)	0.0002	1/3	0.50	3/5	0.49	0/2	0.16
Hossain et al 2013 [61]			17.3 (13.3)/20.5 (16.6)	0.28	3/1	0.36			0/0
Feely et al 2013 [54]	1.1 (0.7)/1.3 (1.3)	0.77			2/3	1.00	10/10	0.28	11/23	0.23
Al Khudairy et al 2013 [60]	4.2 (1)/8 (1)	<0.05	21.2 (11.9)/28.7 (16.4)	>0.05	0/0		0/2		2/4
Wordsworth et al 2013 [55]	1.2/1.2	0.91			0/2	1.00			2/74	0.71
Manaqibwala et al 2014 [64]	2.3 (2.0)/1.9 (2.9)	0.25	10.6 (5.6)/7.4 (7.6)	0.04	1/2	0.25	2/6	1.00	1/6	0.24

Values are mean (Standard Deviation)
^aHaemorrhage includes serious bleeding such as GI Bleed or Intracranial Haemorrhage

ISSN: 1471-2474